Author： Phillips C.
Publisher： Informa Healthcare
ISSN： 1560-4284
Source： International Journal of Experimental Diabetes Research, Vol.3, Iss.3, 2002-07, pp. : 171-178
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
B-lymphocyte therapy for Type 2 diabetes: the `B' side of diabetic medication?
By Grey Shane T
Immunotherapy, Vol. 5, Iss. 7, 2013-07 ,pp. :
Access to resources
Recommend
By Heron John
Australasian Physical & Engineering Sciences in Medicine, Vol. 34, Iss. 1, 2011-04 ,pp. :
Defective clearance of nucleosomes and systemic lupus erythematosus
Trends in Immunology, Vol. 22, Iss. 12, 2001-12 ,pp. :
Is pregnancy an immunocompromising condition?
Reviews in Medical Virology, Vol. 20, Iss. 6, 2010-11 ,pp. :
Spondyloarthropathy: frontier for molecular targets?
By Corr Maripat
Expert Review of Clinical Immunology, Vol. 9, Iss. 4, 2013-04 ,pp. :